Zdrowie i gospodarka · 21/02/2023

FDA Requests Public Comment on Proposed Collection of Blood and Blood Components Information

The Food and Drug Administration is seeking public input on its proposed collection of information related to current good manufacturing practice for blood and blood components, with the goal of reducing the risk of transfusion-transmitted infections.